Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Asia Pacific News Network.
Press releases published on July 10, 2025
Robin Energy Ltd. Announces Vessel Acquisition, Doubling its Fleet
GlobeNewswire
·
July 10, 2025
LIMASSOL, Cyprus, July 10, 2025 (GLOBE NEWSWIRE) -- Robin Energy Ltd. (NASDAQ: RBNE) ("Robin Energy" or the "Company"), an international ship-owning company providing energy transportation services globally, announces that it has entered into an agreement, …
มองย้อนกลับไปในวัน Maono: การเดินทางที่น่าจดจำในเซินเจิ้น
EIN Presswire
·
July 10, 2025
การเฉลิมฉลองสี่วันของนักสร้างสรรค์ชาวไทย การเชื่อมโยงแบรนด์ และพลังของเสียงที่แท้จริง SHENZHEN, GUANGDONG PROVINCE, CHINA, July 10, 2025 /EINPresswire.com/ -- ที่ Maono เราเชื่อว่าเสียงของผู้สร้างสรรค์ทุกคนสมควรได้รับการรับฟังและเฉลิมฉลอง ตั้งแต่วันที่ …
Wealth Strategists Reveal: How Elite Families Use Metaphysics for Business Advantage
EIN Presswire
·
July 10, 2025
HONG KONG, HONG KONG, July 10, 2025 /EINPresswire.com/ -- A growing body of evidence suggests over 50% of ultra-high-net-worth individuals consult metaphysical experts when making major business decisions, according to industry observers. This practice …
Supply Chain Analytics Market to Reach USD 20.93 Billion by 2030, Says Mordor Intelligence
EIN Presswire
·
July 10, 2025
Growing demand for real-time insights into supply chain operations and performance is driving the market growth. HYDERABAD, TELANGANA, INDIA, July 10, 2025 /EINPresswire.com/ -- As per a Mordor Intelligence report, the supply chain analytics industry is …
PDS Biotech Announces Colorectal Cancer Cohort of Phase 2 Clinical Trial with PDS01ADC Met Criteria for Expansion to Stage 2 Following Positive Stage 1 Results
GlobeNewswire
·
July 10, 2025
PRINCETON, N.J., July 10, 2025 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers, today announced …
Cocrystal Pharma to Present Data from Phase 1 Study of First-in-Class Norovirus Protease Inhibitor CDI-988 at the 9th International Calicivirus Conference
GlobeNewswire
·
July 10, 2025
BOTHELL, Wash., July 10, 2025 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) announces that its first-in-class pan-viral protease inhibitor CDI-988 has been selected for an oral presentation at the 9th International Calicivirus Conference being …
Acumen Pharmaceuticals to Present Studies on Cost Savings Associated with Use of pTau217 Screening Assay in Phase 2 ALTITUDE-AD Study and Sabirnetug Oligomer-Selectivity at the Alzheimer’s Association International Conference (AAIC®) 2025
GlobeNewswire
·
July 10, 2025
NEWTON, Mass., July 10, 2025 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets soluble amyloid beta oligomers (AβOs) for the treatment of Alzheimer’s …
Experience.com Partners with Locafy to Redefine Local Digital Marketing in APAC
GlobeNewswire
·
July 10, 2025
SAN FRANCISCO, CA AND PERTH, AUSTRALIA, July 10, 2025 (GLOBE NEWSWIRE) -- Experience.com, a global leader in customer experience, reputation management, and online visibility, today announced the appointment of Locafy Limited (Nasdaq: LCFY), a recognized …
Maxus Mining Announces 2025 Exploration Program at its Penny Copper Project
GlobeNewswire
·
July 10, 2025
VANCOUVER, British Columbia, July 10, 2025 (GLOBE NEWSWIRE) -- Maxus Mining Inc. (“Maxus” or the “Company”) (CSE: MAXM | FRA: R7V), is pleased to provide a summary of the 2025 exploration program (the “Program”) planned on its Penny Copper Project (the “ …
Aventis Energy Announces Partnership with KorrAI Technologies
GlobeNewswire
·
July 10, 2025
Highlights: The Company will leverage KorrAI’s revolutionary systems across the Project with aim to be more efficient in the potential discovery of mineralized outcrops. The cost-efficient technology integrates artificial intelligence, machine learning, …
Ligand Partner Pelthos Therapeutics Launches ZELSUVMI™
GlobeNewswire
·
July 10, 2025
JUPITER, Fla., July 10, 2025 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that its partner Pelthos Therapeutics Inc. (NYSE American: PTHS) has commercially launched ZELSUVMI™ (berdazimer) topical gel 10.3%, the …
BitFuFu Reaffirms Commitment to Sustainable and Efficient Bitcoin Mining in 2025
GlobeNewswire
·
July 10, 2025
SINGAPORE, July 10, 2025 (GLOBE NEWSWIRE) -- BitFuFu Inc. (“BitFuFu” or the “Company”) (NASDAQ: FUFU), a world-leading Bitcoin miner and mining services innovator, today reaffirmed its ongoing commitment to building a more sustainable and energy-efficient …
Genius Group approves and initiates 20% share buyback, buys back one million shares.
GlobeNewswire
·
July 10, 2025
SINGAPORE, July 10, 2025 (GLOBE NEWSWIRE) -- Genius Group Limited (NYSE American: GNS) (“Genius Group” or the “Company”), a leading AI-powered, Bitcoin-first education group, today announced that further to receiving shareholder and board approval for a …
Ichnos Glenmark Innovation (IGI) and AbbVie Announce Exclusive Global Licensing Agreement for ISB 2001, a First-in-Class CD38×BCMA×CD3 Trispecific Antibody
GlobeNewswire
·
July 10, 2025
ISB 2001 is currently in Phase 1 clinical trial in patients with relapsed/refractory multiple myeloma (R/R MM) NEW YORK and NORTH CHICAGO, Ill., July 10, 2025 (GLOBE NEWSWIRE) -- IGI Therapeutics SA, a wholly owned subsidiary of New York-based Ichnos …
EC-Council Releases CEH Hall of Fame 2025 Industry Report
GlobeNewswire
·
July 10, 2025
TAMPA, Fla., July 10, 2025 (GLOBE NEWSWIRE) -- EC-Council, creator of the world-renowned Certified Ethical Hacker (CEH) credential, has unveiled its highly anticipated CEH Hall of Fame 2025 Industry Report a comprehensive analysis spotlighting the world’s …
Ero Copper Intercepts 105 Meters at 1.54% CuEq¹ at Furnas Copper-Gold Project – Successfully Completes Phase 1 Drill Program
GlobeNewswire
·
July 10, 2025
VANCOUVER, British Columbia, July 10, 2025 (GLOBE NEWSWIRE) -- Ero Copper Corp. (TSX: ERO, NYSE: ERO) ("Ero" or the “Company”) is pleased to announce the completion of its Phase 1 drill program at the Furnas Copper-Gold Project ("Furnas" or the "Project"), …
NexGold Infill Drilling Continues to Intersect High-Grade Gold Mineralization at the Goldboro Gold Project, Including 77.30 g/t over 1.25 metres and 19.32 g/t gold over 3.50 metres
GlobeNewswire
·
July 10, 2025
TORONTO, July 10, 2025 (GLOBE NEWSWIRE) -- NexGold Mining Corp. (TSXV: NEXG; OTCQX: NXGCF) (“NexGold” or the “Company”) is pleased to provide additional drill results from a recently-completed 26,854-metre diamond drill program initially announced on …
Pasinex Announces Closing of Shares for Debt Settlement
GlobeNewswire
·
July 10, 2025
TORONTO, July 10, 2025 (GLOBE NEWSWIRE) -- Pasinex Resources Limited (CSE: PSE) (FSE: PNX) ("Pasinex" or the "Company") today announced that it has issued 28,766,306 common shares to certain of its creditors (the “Settlement Shares”) in exchange for …
Kiniero Grade Control Drilling Continues To Return High-Grade Gold Results
GlobeNewswire
·
July 10, 2025
QUEBEC CITY, July 10, 2025 (GLOBE NEWSWIRE) -- West African gold producer and developer Robex Resources Inc (“Robex” or the “Company”) (ASX: RXR | TSX-V: RBX | OTC: RSRBF | Börse Frankfurt: RB4) is pleased to report results from the Mansounia grade control …
Pharvaris Updates Timing of Topline Data Announcement for RAPIDe-3 Pivotal Phase 3 Study to the Fourth Quarter of 2025
GlobeNewswire
·
July 10, 2025
ZUG, Switzerland, July 10, 2025 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to address unmet needs of those living with bradykinin-mediated diseases such as …